Capricor Therapeutics Inc (NASDAQ:CAPR)’s traded shares stood at 1.93 million during the last session, with the company’s beta value hitting 0.91. At the close of trading, the stock’s price was $10.86, to imply a decrease of -2.34% or -$0.26 in intraday trading. The CAPR share’s 52-week high remains $23.40, putting it -115.47% down since that peak but still an impressive 67.59% since price per share fell to its 52-week low of $3.52.
Analysts have given a consensus recommendation of Buy for Capricor Therapeutics Inc (CAPR), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give CAPR a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy.
Capricor Therapeutics Inc (NASDAQ:CAPR) trade information
After registering a -2.34% downside in the last session, Capricor Therapeutics Inc (CAPR) has traded red over the past five days. The 5-day price performance for the stock is 13.60%, and -17.41% over 30 days. With these gigs, the year-to-date price performance is -21.30%.
The extremes give us $10 and $21.5 for target low and target high price respectively. As such, CAPR has been trading -97.97% off suggested target high and 7.92% from its likely low.
CAPR Dividends
Capricor Therapeutics Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 1.55 million shares, or about 4.8645% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $7.39 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF as the top two Mutual Funds with the largest holdings of the Capricor Therapeutics Inc (CAPR) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.13 shares. This is just over 2.48% of the total shares, with a market valuation of $12.3 million. Data from the same date shows that the other fund manager holds a little less at 992.14, or 2.17% of the shares, all valued at about 10.77 million.
